Cargando…

Species‐specific susceptibility to cannabis‐induced convulsions

BACKGROUND AND PURPOSE: Numerous claims are made for cannabis' therapeutic utility upon human seizures, but concerns persist about risks. A potential confounder is the presence of both Δ(9)‐tetrahydrocannabinol (THC), variously reported to be pro‐ and anticonvulsant, and cannabidiol (CBD), wide...

Descripción completa

Detalles Bibliográficos
Autores principales: Whalley, Benjamin J, Lin, Hong, Bell, Lynne, Hill, Thomas, Patel, Amesha, Gray, Roy A, Elizabeth Roberts, C, Devinsky, Orrin, Bazelot, Michael, Williams, Claire M, Stephens, Gary J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487554/
https://www.ncbi.nlm.nih.gov/pubmed/29457829
http://dx.doi.org/10.1111/bph.14165
_version_ 1783414518592831488
author Whalley, Benjamin J
Lin, Hong
Bell, Lynne
Hill, Thomas
Patel, Amesha
Gray, Roy A
Elizabeth Roberts, C
Devinsky, Orrin
Bazelot, Michael
Williams, Claire M
Stephens, Gary J
author_facet Whalley, Benjamin J
Lin, Hong
Bell, Lynne
Hill, Thomas
Patel, Amesha
Gray, Roy A
Elizabeth Roberts, C
Devinsky, Orrin
Bazelot, Michael
Williams, Claire M
Stephens, Gary J
author_sort Whalley, Benjamin J
collection PubMed
description BACKGROUND AND PURPOSE: Numerous claims are made for cannabis' therapeutic utility upon human seizures, but concerns persist about risks. A potential confounder is the presence of both Δ(9)‐tetrahydrocannabinol (THC), variously reported to be pro‐ and anticonvulsant, and cannabidiol (CBD), widely confirmed as anticonvulsant. Therefore, we investigated effects of prolonged exposure to different THC/CBD cannabis extracts on seizure activity and associated measures of endocannabinoid (eCB) system signalling. EXPERIMENTAL APPROACH: Cannabis extract effects on in vivo neurological and behavioural responses, and on bioanalyte levels, were measured in rats and dogs. Extract effects on seizure activity were measured using electroencephalography telemetry in rats. eCB signalling was also investigated using radioligand binding in cannabis extract‐treated rats and treatment‐naïve rat, mouse, chicken, dog and human tissue. KEY RESULTS: Prolonged exposure to cannabis extracts caused spontaneous, generalized seizures, subserved by epileptiform discharges in rats, but not dogs, and produced higher THC, but lower 11‐hydroxy‐THC (11‐OH‐THC) and CBD, plasma concentrations in rats versus dogs. In the same rats, prolonged exposure to cannabis also impaired cannabinoid type 1 receptor (CB(1) receptor)‐mediated signalling. Profiling CB(1) receptor expression, basal activity, extent of activation and sensitivity to THC suggested interspecies differences in eCB signalling, being more pronounced in a species that exhibited cannabis extract‐induced seizures (rat) than one that did not (dog). CONCLUSIONS AND IMPLICATIONS: Sustained cannabis extract treatment caused differential seizure, behavioural and bioanalyte levels between rats and dogs. Supporting radioligand binding data suggest species differences in eCB signalling. Interspecies variations may have important implications for predicting cannabis‐induced convulsions from animal models. LINKED ARTICLES: This article is part of a themed section on 8(th) European Workshop on Cannabinoid Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.10/issuetoc
format Online
Article
Text
id pubmed-6487554
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64875542019-05-06 Species‐specific susceptibility to cannabis‐induced convulsions Whalley, Benjamin J Lin, Hong Bell, Lynne Hill, Thomas Patel, Amesha Gray, Roy A Elizabeth Roberts, C Devinsky, Orrin Bazelot, Michael Williams, Claire M Stephens, Gary J Br J Pharmacol Themed Section: Research Papers BACKGROUND AND PURPOSE: Numerous claims are made for cannabis' therapeutic utility upon human seizures, but concerns persist about risks. A potential confounder is the presence of both Δ(9)‐tetrahydrocannabinol (THC), variously reported to be pro‐ and anticonvulsant, and cannabidiol (CBD), widely confirmed as anticonvulsant. Therefore, we investigated effects of prolonged exposure to different THC/CBD cannabis extracts on seizure activity and associated measures of endocannabinoid (eCB) system signalling. EXPERIMENTAL APPROACH: Cannabis extract effects on in vivo neurological and behavioural responses, and on bioanalyte levels, were measured in rats and dogs. Extract effects on seizure activity were measured using electroencephalography telemetry in rats. eCB signalling was also investigated using radioligand binding in cannabis extract‐treated rats and treatment‐naïve rat, mouse, chicken, dog and human tissue. KEY RESULTS: Prolonged exposure to cannabis extracts caused spontaneous, generalized seizures, subserved by epileptiform discharges in rats, but not dogs, and produced higher THC, but lower 11‐hydroxy‐THC (11‐OH‐THC) and CBD, plasma concentrations in rats versus dogs. In the same rats, prolonged exposure to cannabis also impaired cannabinoid type 1 receptor (CB(1) receptor)‐mediated signalling. Profiling CB(1) receptor expression, basal activity, extent of activation and sensitivity to THC suggested interspecies differences in eCB signalling, being more pronounced in a species that exhibited cannabis extract‐induced seizures (rat) than one that did not (dog). CONCLUSIONS AND IMPLICATIONS: Sustained cannabis extract treatment caused differential seizure, behavioural and bioanalyte levels between rats and dogs. Supporting radioligand binding data suggest species differences in eCB signalling. Interspecies variations may have important implications for predicting cannabis‐induced convulsions from animal models. LINKED ARTICLES: This article is part of a themed section on 8(th) European Workshop on Cannabinoid Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.10/issuetoc John Wiley and Sons Inc. 2018-03-25 2019-05 /pmc/articles/PMC6487554/ /pubmed/29457829 http://dx.doi.org/10.1111/bph.14165 Text en © 2018 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Themed Section: Research Papers
Whalley, Benjamin J
Lin, Hong
Bell, Lynne
Hill, Thomas
Patel, Amesha
Gray, Roy A
Elizabeth Roberts, C
Devinsky, Orrin
Bazelot, Michael
Williams, Claire M
Stephens, Gary J
Species‐specific susceptibility to cannabis‐induced convulsions
title Species‐specific susceptibility to cannabis‐induced convulsions
title_full Species‐specific susceptibility to cannabis‐induced convulsions
title_fullStr Species‐specific susceptibility to cannabis‐induced convulsions
title_full_unstemmed Species‐specific susceptibility to cannabis‐induced convulsions
title_short Species‐specific susceptibility to cannabis‐induced convulsions
title_sort species‐specific susceptibility to cannabis‐induced convulsions
topic Themed Section: Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487554/
https://www.ncbi.nlm.nih.gov/pubmed/29457829
http://dx.doi.org/10.1111/bph.14165
work_keys_str_mv AT whalleybenjaminj speciesspecificsusceptibilitytocannabisinducedconvulsions
AT linhong speciesspecificsusceptibilitytocannabisinducedconvulsions
AT belllynne speciesspecificsusceptibilitytocannabisinducedconvulsions
AT hillthomas speciesspecificsusceptibilitytocannabisinducedconvulsions
AT patelamesha speciesspecificsusceptibilitytocannabisinducedconvulsions
AT grayroya speciesspecificsusceptibilitytocannabisinducedconvulsions
AT elizabethrobertsc speciesspecificsusceptibilitytocannabisinducedconvulsions
AT devinskyorrin speciesspecificsusceptibilitytocannabisinducedconvulsions
AT bazelotmichael speciesspecificsusceptibilitytocannabisinducedconvulsions
AT williamsclairem speciesspecificsusceptibilitytocannabisinducedconvulsions
AT stephensgaryj speciesspecificsusceptibilitytocannabisinducedconvulsions